We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
62 hedge funds and large institutions have $2.74B invested in AbCellera Biologics in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
25.65% more ownership
Funds ownership: 0% → 25.65% (+26%)
Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
62
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$882M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$478M |
| 3 |
O
OrbiMed
New York
|
+$384M |
| 4 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$309M |
| 5 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
+$188M |
Top Sellers
No sellers this quarter